Q2 Beats for BofA and Morgan Stanley, Dow Aims for 7-Day Win Streak, June Retail Sales Miss 7/18/23
Squawk on the Street
00:00
The Pros and Cons of Pfizer, Seattle, and Genes
I think that you want to look at the oil patch, just see the next difference, way too many oils. A lot of private equity companies want to be able to sell. And I don't think that these deals will be just routinely challenged by Lina Khan. The problem with the Amgeol money is that it will raise prices. That I'm not in favor of.
Play episode from 06:37
Transcript
